Trial
NCT03150004
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen
Why stopped
No longer have funding support to complete the pharmacogenetics component.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-30